RICERFARMA S.R.L. – Trademark Portfolio

Entity Type: 03

RICERFARMA S.R.L. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include GENGIGEL and RHINOIAL. The owner is based in Milano.

Via Egadi, 7

Milano 20144 , IT

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

RICERFARMA S.R.L.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does RICERFARMA S.R.L. have?

RICERFARMA S.R.L. has 16 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 7 abandoned, 2 cancelled.

What trademark classes does RICERFARMA S.R.L. file in?

RICERFARMA S.R.L. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are RICERFARMA S.R.L.'s most well-known trademarks?

RICERFARMA S.R.L.'s registered trademark portfolio includes well-known marks such as GENGIGEL and RHINOIAL. These are among 2 currently registered trademarks in the portfolio.

What is RICERFARMA S.R.L.'s trademark registration success rate?

RICERFARMA S.R.L. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.